Pioneering advancements in nutrient, medicine, and vaccine delivery
Biofeyn is a life sciences company pioneering advancements in nutrient, medicine, and vaccine delivery to improve food systems and sustainability. The company develops advanced biosensor and diagnostic platforms using proprietary surface chemistry. Co-founded by Timothy Johns, who previously established programs in planetary health at the World Bank mobilizing over $1 billion for innovation, and Marie-Christine Imbert, a molecular biologist and specialist in sustainable finance with a PhD from the MRC-LMB at Cambridge University. Biofeyn is focused on point-of-care and laboratory diagnostic applications with broad applications across food systems, aquaculture, and healthcare.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountUnknown
Oct 2020
Create a free account to see which investors have funded this company.
Create Free AccountZymergen was a biomanufacturing company using AI and machine learning to engineer microbes for pr...
Xi'an-based subsidiary of Beijing ESWIN Technology Group providing silicon materials and semicond...
Nanotechnology-enabled coatings for automotive and defence sectors
Plasma reactor manufacturer for sustainable advanced materials and batteries.
Arris Composites is the pioneer of next-gen composites for mass market applications, including co...
Develops electrochemical lithium refining technology to produce battery-grade lithium for produce...
